1999
DOI: 10.1074/jbc.274.33.23387
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a CD4 Domain Required for Interleukin-16 Binding and Lymphocyte Activation*

Abstract: Interleukin-16 (IL-16) activates CD4؉ cells, possibly by direct interaction with CD4. IL-16 structure and function are highly conserved across species, suggesting similar conservation of a putative IL-16 binding site on CD4. Comparison of the human CD4 amino acid sequence with that of several different species revealed that immunoglobulin-like domain 4 is the most conserved extracellular region. Potential interaction of this domain with IL-16 was studied by testing murine D4 sequence-based oligopeptides for in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
51
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 60 publications
(52 citation statements)
references
References 38 publications
1
51
0
Order By: Relevance
“…In addition, CD4 oligomerization has been reported to be critical for an efficient interaction of CD4 with other ligands, such as gp160 or IL-16 (6 -10, 41). Moreover, residues within the dimerization site have been shown to be essential for both IL-16 binding and lymphocyte activation (41). Direct evidence for the presence of oligomeric forms of human CD4 in lymphoid and monocytoid cells was provided by Cunningham and colleagues (17).…”
Section: Discussionmentioning
confidence: 93%
“…In addition, CD4 oligomerization has been reported to be critical for an efficient interaction of CD4 with other ligands, such as gp160 or IL-16 (6 -10, 41). Moreover, residues within the dimerization site have been shown to be essential for both IL-16 binding and lymphocyte activation (41). Direct evidence for the presence of oligomeric forms of human CD4 in lymphoid and monocytoid cells was provided by Cunningham and colleagues (17).…”
Section: Discussionmentioning
confidence: 93%
“…It is possible that IL-16 binds in a manner similar to that of gp120 whereby association with CD4 structurally alters CCR5, allowing for direct binding to CCR5. Alternatively, the presence of CCR5 associated with CD4 may structurally alter CD4, thus allowing for stronger interaction of IL-16 with the D4 domain of CD4 (6). The ability of CCR5 to increase IL-16 binding may also result in signal transduction mediated by CCR5.…”
Section: Il-16-induced Migration Of and Binding To Ccr5 ϫ/ϫ Cellsmentioning
confidence: 99%
“…Subsequent studies identified that IL-16 was a chemoattractant for a number of other immune cells such as monocytes, eosinophils, and dendritic cells (3)(4)(5). IL-16 has been characterized as a natural ligand for CD4 (6,7), given that direct association with the D4 domain of CD4 results in activation of p56 lck and phosphatidylinositol 3-kinase (PI 3 kinase) 3 (8). Recent studies have suggested that IL-16 may signal through an alternative receptor in cells from the monocytoid lineage, as CD4 null epidermal dendritic cells and monocytes obtained from CD4 null mice are responsive to IL-16 (9,10).…”
mentioning
confidence: 99%
“…[15][16][17][18] Expression of IL-16 by the bronchial epithelium in patients with asthma, by the dermis and epidermis in patients with atopic dermatitis, and by synovial fibroblasts in patients with rheumatoid arthritis was found to correlate with CD4 ϩ cell influx. 15,[17][18][19] Furthermore, recombinant IL-16 induced chemotaxis of CD4 ϩ T cells in vitro through interaction with CD4, 13,14 and HIV-1 gp120 binding to CD4 increased CD4 T-cell activation and directed cell migration in vitro. 20,21 In the current study, we expanded on our previous findings and determined that the level of CD4 cell-surface expression on CD8 ϩ T cells is directly proportional to the level of costimulation with T-cell receptor and CD28.…”
Section: Introductionmentioning
confidence: 99%